TVRD
Tvardi Therapeutics
$0.86
−$0.02 (−2.71%)Oct 29, 2026
Key metrics
The numbers that frame TVRD today
- Market cap
- $11.51M
- ROIC
- 1,654.3%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.83
- 52wk High
- $5.69
Growth
Revenue and earnings trend for TVRD
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about TVRD
Is Tvardi Therapeutics a good buy?
No. Tvardi Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup.
What is the market capitalization of TVRD?
Tvardi Therapeutics's market capitalization is $11.51M.
What is the 52-week high for TVRD stock?
The 52-week high for Tvardi Therapeutics is $5.69. The current close of $0.86 is 84.8% below that high.
What is the 52-week low for TVRD stock?
The 52-week low for Tvardi Therapeutics is $0.83. The current close of $0.86 is 3.9% above that low.
Does TVRD stock pay dividends?
Tvardi Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for TVRD?
Tvardi Therapeutics's Debt / Equity ratio is 0.02.